Bioclinical Research Alliance | Miami, FL

Research site
7821 Coral Way Suite 132, Miami, Florida, United States of America
Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site


5 of 6
Status: Active
Trial type: Interventional
Funder type: Industry

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Once-daily Basal Insulin With or Without Metformin (REIMAGINE 3)

This study will look at how much CagriSema helps people with type 2 diabetes lower their blood sugar and body weight. CagriSema is a new investigatio...

Type 2 Diabetes
Drug: Placebo
Drug: Cagrilintide

The study will look at how well CagriSema helps people lower their blood sugar and body weight. CagriSema is a new weekly medicine that combines two...

Type 2 Diabetes Mellitus
Drug: Cagrilintide
Drug: Semaglutide

The primary objectives of this study are to assess the safety, tolerability, and efficacy of ABP-671 in lowering serum uric acid (sUA) in participant...

Drug: ABP-671
Drug: Allopurinol

This is a multicenter, randomized, double-blind, Phase 2b/3 study to evaluate the efficacy and safety of ABP-671. Part 1 of the study will compare th...

Drug: ABP-671
Other: Placebo

The purpose of this study is to measure the proportion of participants who are infected with severe acute respiratory syndrome coronavirus 2 (SARS-Co...

SARS-CoV-2 Infection
Drug: Placebo
Drug: S-217622

Trial conditions

Diabetes Mellitus (2 trials)
Gout (2 trials)
Type 2 Diabetes Mellitus (2 trials)
COVID-19 (1 trial)
Communicable Diseases (1 trial)
Infections (1 trial)
Psoriasis (1 trial)

Clinical trials

Find clinical trialsTrials by location


© Copyright 2024 Veeva Systems